Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome

Abstract

Knowledge of a patient's HLA-DR type and RF status allows clinically useful prediction of erosive disease; patients possessing Dw4/Dw14 represent a particularly high-risk subgroup.